Estrella Immunopharma, Inc. ( ESLAW) - Key Metrics
ESLAW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.05 | -$0.04 | -$0.04 |
| 2026Q1 | $0 | -$0.05 | -$0.16 | -$0.16 |
| 2025Q4 | $0 | -$0.02 | $0 | $0 |
| 2025Q3 | $0 | -$0.13 | -$0.02 | -$0.02 |
| 2025Q2 | $0 | -$0.15 | -$0.01 | -$0.01 |
ESLAW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.20 |
| 2026Q1 | 0% | -5.30 |
| 2025Q4 | 0% | -24.07 |
| 2025Q3 | 0% | -2.21 |
| 2025Q2 | 0% | -1.60 |
ESLAW
Price: $0.06
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 22.2 million